Biotricity is a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. The company announced Tuesday that it has finalized the expansion of their long-term research partnership with the University of Calgary.
The vision behind the partnership is to apply biotricity’s technology of remote monitoring working with clinical leaders in a number of divisions. Biotricity will develop a prototype remote monitoring mobile devices in several clinical settings, including peri-operative medicine, maternal/fetal medicine and acute and chronic care medicine in order to facilitate the application of “smart” medical grade wearables to the hospital and out-patient settings.
Founder and CEO of Biotricity, Waqaas Al-Siddiq, said in a statement, “We are thrilled to expand on our already successful relationship with the University of Calgary… Their participation is an important step in helping us realize our goal, which is to take what we learn from this research and align it with our investigation into predictability and artificial intelligence for the next generation of healthcare.”
Dr. David Liepert, a clinical associate professor in the Department of Anesthesia and Peri-Operative Medicine added: “We look forward to capitalizing on Mr. Al-Siddiq's recognized expertise in wearable biometric monitoring, connectivity and data processing for both our University of Calgary’s Medical and Biomedical Engineering students through his advisory role under this expanded partnership.”